Osmotica Pharmaceuticals plc Business Finance Contracts & Agreements
21 Contracts & Agreements
- Facility Agreements (1 contract)
- Note Agreements (3)
- Purchase Agreements (2)
- Share Agreements (5)
- Shareholders Agreements (2)
- Underwriting Agreements (3)
- Warrant Agreements (5)
- DIP Facility Agreement, dated as of October 16, 2023, by and between the Debtors, Athyrium Opportunities IV Acquisition LP, as administrative agent and collateral agent, and... (Filed With SEC on October 20, 2023)
- Form of Securities Purchase Agreement, dated August 15, 2023 (Filed With SEC on August 18, 2023)
- Form of Placement Agent Ordinary Warrant (Filed With SEC on August 18, 2023)
- Form of Series A-2 Ordinary Warrant (Filed With SEC on August 18, 2023)
- Form of Series A-1 Ordinary Warrant (Filed With SEC on August 18, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on August 18, 2023)
- Third Amendment to Note Purchase Agreement, dated August 13, 2023, by and among RevitaLid Pharmaceutical Corp., the Guarantors party thereto, the Purchasers party thereto and... (Filed With SEC on August 14, 2023)
- Second Amendment to Note Purchase Agreement, dated March 8, 2023, by and among RevitaLid (Filed With SEC on March 20, 2023)
- RVL Pharmaceuticals plc Amended and Restated 2018 Employee Share Purchase Plan (Filed With SEC on March 30, 2022)
- Form of Warrant (Filed With SEC on October 12, 2021)
- Underwriting Agreement, dated October 6, 2021, by and between Osmotica Pharmaceuticals plc and H.C. Wainwright & Co., LLC (Filed With SEC on October 12, 2021)
- Share Subscription Agreement dated October 1, 2021, between Osmotica Pharmaceuticals plc and Athyrium Opportunities IV Acquisition LP (Filed With SEC on October 6, 2021)
- Note Purchase Agreement dated October 1, 2021, between Osmotica Pharmaceutical Corp., Osmotica Pharmaceuticals plc, Osmotica Holdings US LLC, Athyrium Opportunities IV Acquisition... (Filed With SEC on October 6, 2021)
- Purchase and Sale Agreement, dated as of June 24, 2021, by and among Osmotica Pharmaceuticals plc, Acella Holdings, LLC, Alora Pharmaceuticals, LLC and the Sellers listed therein (Filed With SEC on June 30, 2021)
- Osmotica Pharmaceuticals plc Amended and Restated 2018 Employee Share Purchase Plan (Filed With SEC on August 11, 2020)
- Underwriting Agreement, dated July 13, 2019, by and between Osmotica Pharmaceuticals plc and Credit Suisse Securities (USA) LLC (Filed With SEC on July 15, 2020)
- Form of Underwriting Agreement (Filed With SEC on January 6, 2020)
- Osmotica Pharmaceuticals plc Amended and Restated 2018 Employee Share Purchase Plan (Filed With SEC on August 8, 2019)
- Shareholders' Agreement (Filed With SEC on March 28, 2019)
- OSMOTICA PHARMACEUTICALS PLC 2018 EMPLOYEE SHARE PURCHASE PLAN (Filed With SEC on October 1, 2018)
- Form of Shareholders' Agreement (Filed With SEC on October 1, 2018)
